DEPT LOGO

 Home Page
 Department Divisions
 Personnel
 Brochures & Newsletters
 Clin. Training Programs
 Res. Training Programs
 Consultation Services
 Case Studies
 Case of the Month
 Online CME
 Seminars
 Residents Web
 Feedback
 Links
 Links


Department of Pathology
University of Pittsburgh
School of Medicine
S-417 BST
200 Lothrop Street
Pittsburgh, PA 15261
(412) 648-1260


v-line

Department of Pathology - Faculty


Michael A. Nalesnik, M.D.

Dr. Nalensnik
Dr. Nalesnik is a member of the Division of Transplantation Pathology. More information about this division is available here.

Office Location:
Division of Transplantation Pathology
Department of Pathology
UPMC-Montefiore University Hospital
Suite E-738
200 Lothrop Street
Pittsburgh, PA 15213-2582

Contact Information:
Office Phone: (412)647-2094
Fax: (412)647-5237
Email Address: nalesnikma@upmc.edu

Research Interests:

Dr.Michael A. Nalesnik is a Professor of Pathology in the Division of Hepatic and Transplantation Pathology. He obtained his M.D. from Rutgers Medical School in 1977 and received his Pathology training at the University of Pittsburgh Medical Center. He served as Director of Histology and Immunocytochemistry at Presbyterian Hospital in Pittsburgh from 1982 to 1987. He became Chief of Anatomic Pathology at the Pittsburgh Veteran's Administration Medical Center in 1987. He returned to the University to join the newly-formed Division of Hepatic and Transplantation Pathology in 1991. Dr. Nalesnik's specific research interest centers on post transplant lymphoproliferative disorders which occur in association with Epstein-Barr virus infection. He is also involved with the problem of liver neoplasia in transplant candidates and patients.

Selected Publications:

View Dr. Nalesnik's publications on PubMed

Nalesnik M. Hepatitis C, Helicobacter, lymphoma...and liver transplantation. Liver Transpl. 2005 Jul;11(7):733-736.

Nalesnik MA, Abu-Elmagd K, Green M, Martin D, Bond G, Wu T, Jaffe R, Mazariegos G, Demetris AJ, Reyes J. “Posttransplant Lymphoproliferative Disorders in Intestinal Transplant Recipients” (oral presentation). XX International Congress of The Transplantation Society, Vienna, Austria, Sept. 5-10, 2004

Nakao A, Otterbein LE, Overhaus M, Sarady JK, Tsung A, Kimizuka K, Nalesnik MA, Kaizu T, Uchiyama T, Liu F, Murase N, Bauer AJ, Bach FH. Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology. 2004 Aug;127(2):595-606.

Neto JS, Nakao A, Kimizuka K, Romanosky AJ, Stolz DB, Uchiyama T, Nalesnik MA, Otterbein LE, Murase N. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol. 2004 Nov;287(5):F979-89

Funch DP, Ko HH, Travasso J, Mechlowicz J, Nalesnik MA, Kew C III, Walker AM: Association between Mycophenolate Mofetil (MMF) and Development of Post-Transplant Lymphoproliferative Disorder in Renal Transplant Patients in the U.S. American Transplantation Congress, Washington, D.C., May 30 - June 4, 2003.



Copyright 1995-2007   
Department of Pathology   
Univ. Pittsburgh Sch. Medicine